In recent years, doctors have extended patients' lifespan by adding immune checkpoint inhibitors ... with a specific inhibitor. “In SCLC, we don’t really have that,” he said. Instead, in each “flavor” ...

Small cell lung cancer (SCLC) may increase the risk of pneumonia due to a weakened immune system or structural changes to the lungs. SCLC is one of the two main types of lung cancer. Pneumonia is ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have used DNA testing and other methods to identify a previously uncharacterized subtype of small cell lung cancer (SCLC). As they report in ...

"This is the largest retrospective study to assess and demonstrate that immune-related toxicity is positively associated with improved clinical outcomes in patients with ES-SCLC [extensive-stage ...

Immune-related adverse events have now proven to be a problem in two of Merck’s phase 3 TIGIT trials. Merck is continuing to evaluate vibostolimab with Keytruda in three phase 3 non-SCLC trials ...